Delivery Order SPE2DB22D1106-SPE2DB24FEFD2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,516.32 Firm Fixed Price Delivery Order is for the supply of Envarsus XR 1 mg tablets, a medication used in the treatment of certain medical conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,216.11 firm fixed price delivery order is for the supply of Envarsus XR 1 mg tablets. This contract is not associated with any set-aside designation. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,007.34, is for the delivery of Envarsus XR 1 mg tablets in quantities of 100. The contract is a firm fixed-price delivery order and is not set aside for any particular business type. Amerisourcebergen Drug Corp is the prime contractor, and the contract will be performed in Conshohocken,...
- This federal contract award, valued at $1,621.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, for the delivery of Envarsus XR 1 mg tablets. The contract is a firm fixed price delivery order with an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,216.11 fixed-price delivery order is for the supply of 4,565,469,346 units of the prescription medication Envarsus XR 1 mg tablet. The contract has an ultimate completion date of September 6, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded numerous federal contracts to supply a wide...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $4,459.81 Firm Fixed Price delivery order is for Envarsus XR 0.75 mg tablets, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award, valued at $1,465.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of Envarsus XR 1 mg tablets in quantities of 30, with a period of performance through April 30, 2024. This is a firm-fixed-price delivery order contract, and there is no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award, valued at $1,553.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of ENVARSUS XR 1 MG TABLET 30S, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,711.95 firm fixed-price delivery order is for the supply of Envarsus XR 4 mg tablets, a medication used in organ transplant patients. The contract has an ultimate completion date of May 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,423.90 Firm Fixed Price Delivery Order contract, which runs through February 2025, is for the supply of Envarsus XR 4 mg tablets. The award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEFD2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical services company AmerisourceBergen Corporation. The $2,442.80 firm fixed price delivery order is for the supply of Envarsus XR 1 mg tablets. The award is a task order under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that was previously awarded solely to AmerisourceBergen Drug Corp. This IDC serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have any set-aside designation. AmerisourceBergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor responsible for fulfilling this order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 3/15/24 |